novo glp 1 drugs GLP-1 may have a beneficial effect across many types of cancer Novo's patent expires in India:

Psychiatry 55 , 501511

Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts

(PubMed) Fry PC, Fox HM, Tao HG

10,33 With regard to the secondary outcome of HF hospitalisation, the results were neutral, with LEADER showing a non-significant relative risk reduction (RRR) of 13% with liraglutide compared with placebo and SUSTAIN-6 showing no significant difference between the semaglutide and placebo treatment groups

Price is often a factor: Because metformin is available as a generic drug, its widely available and much more affordable

1a and Extended Data Figs